An MJF Grant Is Helping Amicus Therapeutics Focus On Parkinson’s Disease

It’s difficult to find a family that has not been touched by struggles of common diseases. Every time a family member, a friend, or an acquaintance battles a neuromuscular disease, it illustrates the need for cures. Amicus Therapeutics is a company that is dedicated to expanding the capabilities of labs and research facilities that focus on pinpointing causes and cures of common diseases.

 

One disease has reached a pinnacle in social awareness, and wide public need, because of the involvement of certain celebrities. In the 1990s Michael J. Fox, one of America’s favorite actors, announced publically that he suffers from Parkinson’s Disease. This malady of the brain and nervous system is still one of the most mysterious and difficult diseases to understand (YourBeautyCraze). Amicus Therapeutics is actively involved with identifying the causes of this disease. Amicus Therapeutics does not treat diseases, but it works to locate causes of diseases at the cellular level.

 

The Michael J. Fox Foundation is absolutely the most prominent Parkinson’s Disease research funding entity. Since its inception, it has collected and distributed almost $1 billion in research funds (GoogleFinance). As a leading biomedical research group, Amicus Therapeutics has earned the attention of this foundation.

 

In 2010, Amicus Therapeutics received a $500,000 grant from the Michael J. Foundation. This is one of the largest awards that the foundation has ever given. It was made because the Amicus Therapeutics model of research is world class, and is consistently at the forefront of disease research. Very few organizations are so dedicated to understanding the role that proteins have in the realm of neuro diseases as Amicus Therapeutics. People suffering from conditions like Parkinson’s Disease constantly exhibit hope that a cause and cure will be identified soon. Amicus Therapeutics is a company that has a great chance on making these types of discoveries.